BVS FY 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$512M+0.0% YoY

Gross Profit

$328M64.1% margin

Operating Income

-$82M-16.0% margin

Net Income

-$156M-30.5% margin

EPS (Diluted)

$-2.49

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$811M

Total Liabilities

$590M

Stockholders' Equity

$174M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$512M	$512M	+0.0%
Gross Profit	$328M	$331M	-0.9%
Operating Income	-$82M	-$167M	+51.1%
Net Income	-$156M	-$159M	+1.6%